224 related articles for article (PubMed ID: 28370282)
1. Increased risk of comorbid rheumatic disorders in vitiligo patients: A nationwide population-based study.
Choi CW; Eun SH; Choi KH; Bae JM
J Dermatol; 2017 Aug; 44(8):909-913. PubMed ID: 28370282
[TBL] [Abstract][Full Text] [Related]
2. Comorbidity profiles in association with vitiligo: a nationwide population-based study in Taiwan.
Chen YT; Chen YJ; Hwang CY; Lin MW; Chen TJ; Chen CC; Chu SY; Lee DD; Chang YT; Liu HN
J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1362-9. PubMed ID: 25510261
[TBL] [Abstract][Full Text] [Related]
3. Association of inflammatory bowel disease with ankylosing spondylitis and rheumatoid arthritis: A nationwide population-based study.
Bae JM; Choo JY; Kim KJ; Park KS
Mod Rheumatol; 2017 May; 27(3):435-440. PubMed ID: 27459267
[TBL] [Abstract][Full Text] [Related]
4. Comorbid autoimmune diseases in patients with vitiligo: A cross-sectional study.
Gill L; Zarbo A; Isedeh P; Jacobsen G; Lim HW; Hamzavi I
J Am Acad Dermatol; 2016 Feb; 74(2):295-302. PubMed ID: 26518171
[TBL] [Abstract][Full Text] [Related]
5. Incidence and risk of developing rheumatic diseases in 19,724 patients with palindromic rheumatism in South Korea: A nationwide population-based study.
Ahn JK; Hwang J; Seo GH
Joint Bone Spine; 2021 May; 88(3):105128. PubMed ID: 33359768
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of systemic autoimmune rheumatic diseases and clinical significance of ANA profile: data from a tertiary hospital in Shanghai, China.
Yang Z; Ren Y; Liu D; Lin F; Liang Y
APMIS; 2016 Sep; 124(9):805-11. PubMed ID: 27328803
[TBL] [Abstract][Full Text] [Related]
7. Association between dementia and systemic rheumatic disease: A nationwide population-based study.
Park H; Yim DH; Ochirpurev B; Eom SY; Choi IA; Ju G; Kim JH
PLoS One; 2021; 16(3):e0248395. PubMed ID: 33711047
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and incidence of vitiligo and associated comorbidities: a nationwide population-based study in Korea.
Kang H; Lee S
Clin Exp Dermatol; 2023 Apr; 48(5):484-489. PubMed ID: 36656897
[TBL] [Abstract][Full Text] [Related]
9. Vitiligo and overt thyroid diseases: A nationwide population-based study in Korea.
Bae JM; Lee JH; Yun JS; Han B; Han TY
J Am Acad Dermatol; 2017 May; 76(5):871-878. PubMed ID: 28238453
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune rheumatic diseases increase dementia risk in middle-aged patients: A nationwide cohort study.
Lin TM; Chen WS; Sheu JJ; Chen YH; Chen JH; Chang CC
PLoS One; 2018; 13(1):e0186475. PubMed ID: 29304089
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and comorbidities associated with hidradenitis suppurativa in Korea: a nationwide population-based study.
Lee JH; Kwon HS; Jung HM; Kim GM; Bae JM
J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1784-1790. PubMed ID: 29761904
[TBL] [Abstract][Full Text] [Related]
12. Risk of immune-mediated inflammatory diseases in newly diagnosed ankylosing spondylitis patients: a population-based matched cohort study.
Chen HH; Chao WC; Chen YH; Hsieh TY; Lai KL; Chen YM; Hung WT; Lin CT; Tseng CW; Lin CH
Arthritis Res Ther; 2019 Aug; 21(1):196. PubMed ID: 31464632
[TBL] [Abstract][Full Text] [Related]
13. Comorbidities in vitiligo: comprehensive review.
Dahir AM; Thomsen SF
Int J Dermatol; 2018 Oct; 57(10):1157-1164. PubMed ID: 29808541
[TBL] [Abstract][Full Text] [Related]
14. Risks of Comorbidities in Patients With Palmoplantar Pustulosis vs Patients With Psoriasis Vulgaris or Pompholyx in Korea.
Kim DH; Lee JY; Cho SI; Jo SJ
JAMA Dermatol; 2022 Jun; 158(6):650-660. PubMed ID: 35476054
[TBL] [Abstract][Full Text] [Related]
15. Sex- and age-specific incidence of autoimmune rheumatic diseases in the Chinese population: a Taiwan population-based study.
See LC; Kuo CF; Chou IJ; Chiou MJ; Yu KH
Semin Arthritis Rheum; 2013 Dec; 43(3):381-6. PubMed ID: 23916348
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of vitiligo and associated comorbidities in Korea.
Lee H; Lee MH; Lee DY; Kang HY; Kim KH; Choi GS; Shin J; Lee HJ; Kim DH; Kim TH; Lee AY; Lee SC; Lee S; Kim KW; Hann SK; Park CJ; Oh SH
Yonsei Med J; 2015 May; 56(3):719-25. PubMed ID: 25837178
[TBL] [Abstract][Full Text] [Related]
17. Increased Risk of Vitiligo Following Anti-Tumor Necrosis Factor Therapy: A 10-Year Population-Based Cohort Study.
Bae JM; Kim M; Lee HH; Kim KJ; Shin H; Ju HJ; Kim GM; Park CJ; Park HJ
J Invest Dermatol; 2018 Apr; 138(4):768-774. PubMed ID: 29175284
[TBL] [Abstract][Full Text] [Related]
18. Markedly Reduced Risk of Internal Malignancies in Patients With Vitiligo: A Nationwide Population-Based Cohort Study.
Bae JM; Chung KY; Yun SJ; Kim H; Park BC; Kim JS; Seo SH; Ahn HH; Lee DY; Kim YC; Park HJ; Kim M
J Clin Oncol; 2019 Apr; 37(11):903-911. PubMed ID: 30785828
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory bowel disease is associated with an increased risk of inflammatory skin diseases: A population-based cross-sectional study.
Kim M; Choi KH; Hwang SW; Lee YB; Park HJ; Bae JM
J Am Acad Dermatol; 2017 Jan; 76(1):40-48. PubMed ID: 27793451
[TBL] [Abstract][Full Text] [Related]
20. Comorbidities associated with vitiligo: a ten-year retrospective study.
Sheth VM; Guo Y; Qureshi AA
Dermatology; 2013; 227(4):311-5. PubMed ID: 24107643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
